D. E. Shaw & Co., Inc. Amgen Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $5.38 Million - $5.87 Million	-17,400 Reduced 6.32%	257,900 $83.1 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $19.8 Million - $24 Million	75,300 Added 37.65%	275,300 $86 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $25.5 Million - $30.8 Million	95,000 Added 90.48%	200,000 $56.9 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $7.11 Million - $8.02 Million	-27,800 Reduced 20.93%	105,000 $30.2 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $6.56 Million - $8.14 Million	30,000 Added 29.18%	132,800 $35.7 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $9.17 Million - $10.8 Million	42,800 Added 71.33%	102,800 $22.8 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $6.77 Million - $8.26 Million	30,000 Added 100.0%	60,000 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $6.87 Million - $8.73 Million	30,000 New	30,000 $7.88 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $968,982 - $1.08 Million	4,200 Added 4.31%	101,600 $24.7 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $109,635 - $121,285	-500 Reduced 0.51%	97,400 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $2.21 Million - $2.53 Million	11,100 Added 12.79%	97,900 $22 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $9.17 Million - $10.7 Million	-43,200 Reduced 33.23%	86,800 $18.5 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $21 Million - $23.3 Million	90,000 Added 225.0%	130,000 $31.7 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $8.34 Million - $9.72 Million	37,600 Added 1566.67%	40,000 $9.95 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $2.82 Million - $3.13 Million	-12,000 Reduced 83.33%	2,400 $610,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $29.2 Million - $35.8 Million	-147,400 Reduced 91.1%	14,400 $3.4 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $3.28 Million - $4.35 Million	-18,000 Reduced 10.01%	161,800 $32.8 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $21.5 Million - $27.6 Million	113,600 Added 171.6%	179,800 $43.3 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $4.56 Million - $5.47 Million	26,200 Added 65.5%	66,200 $12.8 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $6.1 Million - $6.87 Million	33,700 Added 534.92%	40,000 $7.6 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $13.5 Million - $15.7 Million	-75,600 Reduced 92.31%	6,300 $1.23 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $4.97 Million - $5.6 Million	-26,800 Reduced 24.66%	81,900 $17 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $4.07 Million - $4.57 Million	-24,500 Reduced 18.39%	108,700 $20.1 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $15.6 Million - $17.4 Million	92,200 Added 224.88%	133,200 $23.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.86 Million - $7.83 Million	41,000	41,000 $7.64 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account